Strategic Growth RadNet acquisition and subsequent growth phase indicate Quantib may be open to broader enterprise partnerships and larger contract opportunities beyond standalone solutions.

Prostate AIExpansion Recent integration with Focal Healthcare and ongoing Prostate solution updates suggest a fertile entry point for co-developed workflows and cross-sell of AI-assisted diagnostic modules.

Brain ImagingAdv Strong momentum in brain atrophy and white matter analysis (ND 2.0) positions Quantib as a potential partner for neurodegenerative disease screening programs and hospital AI accelerators.

FinancialLevers Current revenue under one million with modest external funding but an overall eight million dollars raised; opportunity to frame scalable deployment, ROI case studies, and phased implementation with cost justification.

TechEnabledWin Utilize Quantib’s tech stack and FDA-cleared/AI workflow integration capabilities to target hospitals and imaging centers seeking interoperable AI solutions with established data governance and analytics tooling.